TY - JOUR
T1 - Brief report
T2 - Association of sex chromosome anomalies with childhood- onset psychotic disorders
AU - Kumra, Sanjiv
AU - Wiggs, Edythe
AU - Krasnewich, Donna
AU - Meck, Jeanne
AU - Smith, Ann C.M.
AU - Bedwell, Jeffrey
AU - Fernandez, Thomas
AU - Jacobsen, Leslie K.
AU - Lenane, Marge
AU - Rapoport, Judith L.
PY - 1998/3
Y1 - 1998/3
N2 - Objective: An apparent excess of sex chromosome aneuploidies (XXY, XXX, and possibly XYY) has been reported in patients with adult-onset schizophrenia and with unspecified psychoses. This study describes the results of cytogenetic screening carried out for pediatric patients meeting DSM-III-R criteria for childhood-onset schizophrenia (COS) and a subgroup of patients with childhood-onset psychotic disorder not otherwise specified, provisionally labeled by the authors as multidimensionally impaired (MDI). Method: From August 1990 to July 1997, karyotypes were determined for 66 neuroleptic-nonresponsive pediatric patients (28 MDI, 38 COS), referred to the National Institute of Mental Health for an inpatient treatment trial of clozapine. Results: Four (6.1%) of 66 patients (3 MDI, 1 COS) were found to have sex chromosome anomalies (mosaic 47,XXY; 47,XXY; 47,XYY; mosaic 45,XO, respectively), which is higher than the expected rate of 1 per 426 children or 2.34 per 1,000 in the general population (4/66 versus 1/426, χ2 = 19.2, df = 1, p = .00001). All cases had been previously undiagnosed. Conclusions: These findings lend support to a hypothesis that a loss of balance of gene products on the sex chromosomes may predispose affected individuals to susceptibility to additional genetic and environmental insults that result in childhood-onset psychotic disorders. Karyotyping of children with psychotic disorders should be routine.
AB - Objective: An apparent excess of sex chromosome aneuploidies (XXY, XXX, and possibly XYY) has been reported in patients with adult-onset schizophrenia and with unspecified psychoses. This study describes the results of cytogenetic screening carried out for pediatric patients meeting DSM-III-R criteria for childhood-onset schizophrenia (COS) and a subgroup of patients with childhood-onset psychotic disorder not otherwise specified, provisionally labeled by the authors as multidimensionally impaired (MDI). Method: From August 1990 to July 1997, karyotypes were determined for 66 neuroleptic-nonresponsive pediatric patients (28 MDI, 38 COS), referred to the National Institute of Mental Health for an inpatient treatment trial of clozapine. Results: Four (6.1%) of 66 patients (3 MDI, 1 COS) were found to have sex chromosome anomalies (mosaic 47,XXY; 47,XXY; 47,XYY; mosaic 45,XO, respectively), which is higher than the expected rate of 1 per 426 children or 2.34 per 1,000 in the general population (4/66 versus 1/426, χ2 = 19.2, df = 1, p = .00001). All cases had been previously undiagnosed. Conclusions: These findings lend support to a hypothesis that a loss of balance of gene products on the sex chromosomes may predispose affected individuals to susceptibility to additional genetic and environmental insults that result in childhood-onset psychotic disorders. Karyotyping of children with psychotic disorders should be routine.
KW - Childhood-onset psychotic disorders
KW - Neurodevelopmental impairments
KW - Sex chromosome anomalies
UR - http://www.scopus.com/inward/record.url?scp=0031937498&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031937498&partnerID=8YFLogxK
U2 - 10.1097/00004583-199803000-00014
DO - 10.1097/00004583-199803000-00014
M3 - Article
C2 - 9519634
AN - SCOPUS:0031937498
SN - 0890-8567
VL - 37
SP - 292
EP - 296
JO - Journal of the American Academy of Child and Adolescent Psychiatry
JF - Journal of the American Academy of Child and Adolescent Psychiatry
IS - 3
ER -